Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Original title: “HR 7817: To amend the Patient Protection and Affordable Care Act to ensure that taxpayer funds for health insurance coverage are available only to authorized individuals, and for other purposes.”

Referred to the House Committee on Veterans' Affairs.

Original title: “HR 7838: To amend title 38, United States Code, to establish a procurement program to facilitate the ability of the medical centers of the Department of Veterans Affairs to make direct procurements of original artwork from veterans who are patients, and for other purposes.”

TrumpRX and DTC sales may expand prescription drug access, but they will not solve the affordability crisis by themselves.

Original title: “Direct-to-Consumer Drugs Are Not a Panacea for High Costs”

Read twice and referred to the Committee on Veterans' Affairs.

Original title: “S 3314: A bill to direct the Secretary of Veterans Affairs to expand a directive of the Veterans Health Administration regarding informed consent to apply to certain types of medications.”

Committee on Veterans' Affairs. Hearings held.

Original title: “S 2061: A bill to require the Interagency Working Group on Toxic Exposure to conduct research on the diagnosis and treatment of health conditions of descendants of individuals exposed to toxic substances while serving as members of the Armed Forces, and for other purposes.”

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Original title: “S 864: A bill to amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes.”

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Original title: “HR 7352: To amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.”

landmark pediatric cancer legislation aims to incentivize research

Original title: “Landmark Pediatric Cancer Legislation Aims to Incentivize Research.”

The Administration for Children and Families (ACF) proposes to remove the requirements issued in the final rule Designated Placement Requirements Under Titles IV-E and IV-B for LGBTQI+ Children (89 FR 34818) that was published on April 30, 2024. The final rule required title IV-E/IV-B agencies to ensure that a Designated Placement is available for all children who self-identify with an alternative sexual orientation or self-identify as something other than their sex in foster care who request or

Original title: “Designated Placement Requirements Under Titles IV-E and IV-B for LGBTQI+ Children; Rescission”

The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for ENSACOVE and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.

Original title: “Determination of Regulatory Review Period for Purposes of Patent Extension; ENSACOVE”

The Food and Drug Administration (FDA, the Agency, or we) is announcing the establishment of a docket to solicit public comment on what specifications for in-home disposal systems, if application holders are required to make them available under the Opioid Analgesic Risk Evaluation and Mitigation Strategy, would be necessary to show that these systems may mitigate the serious risks of abuse or overdose involving these medications.

Original title: “Developing Specifications for In-Home Disposal Systems for Opioid Analgesics Dispensed in an Outpatient Setting; Establishment of a Public Docket; Request for Comments”

This document corrects technical errors in the proposed rule that appeared in the February 11, 2026, Federal Register titled "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program."

Original title: “Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction”

Referred to the House Committee on Energy and Commerce.

Original title: “HR 7790: To amend the HITECH Act to allow an individual to obtain a copy of such individual's protected health information at no cost unless certain circumstances apply, and for other purposes.”

This report describes exposures to chemical munitions during commercial fishing operations.

Original title: “Notes from the Field: Exposures to Chemical Munitions During Commercial Fishing Operations — New Jersey, 2016–2023”

A service tailored to people with workplace-based insurance coverage represents a new way for Lilly to bypass insurers and expand use of its popular obesity shot.

Original title: “Lilly targets employers in new bid to broaden access to obesity drugs”

The Accelerating Clinical Trials in the EU (ACT EU) initiative has published a draft guidance document outlining how clinical trials should be conducted during public health…

Original title: “New guidance on the conduct of clinical trials during public health emergencies in the EU”

The U.S. Food and Drug Administration today issued a Request for Information (RFI) seeking public comment on potential new standards for in-home opioid disposal products.

Original title: “FDA to Address Unused Opioids in American Homes ”

Read twice and referred to the Committee on Finance.

Original title: “S 3492: A bill to amend titles XVIII and XIX of the Social Security Act to require skilled nursing facilities, nursing facilities, intermediate care facilities for the intellectually disabled, and inpatient rehabilitation facilities to permit essential caregivers access during any period in which regular visitation is restricted.”

Read twice and referred to the Committee on Finance.

Original title: “S 2612: A bill to amend title XVIII of the Social Security Act to include physical therapists and occupational therapists as health professionals for purposes of the annual wellness visit under the Medicare program, and for other purposes.”

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Original title: “S 2167: A bill to permit nurse practitioners and physician assistants to furnish necessary services, appliances, and supplies to individuals receiving medical benefits for illnesses.”